Skip to main content
. 2016 Dec 28;37(2):761–767. doi: 10.3892/or.2016.5337

Figure 5.

Figure 5.

(A and B) ARRB1 transfection in vivo decreases tumor growth, when compared to the control group (P=0.038). This indicated that tumors were more sensitive to cisplatin.